Connect with us

Cannabis News

Gavita International launches Agrolux Operating System

Published

2 months ago

on

During Fruit Logistica, Gavita International launches the future Agrolux Operating System and the LYRA modular product platform. “The latest developments highlight Gavita International’s evolution into a fully integrated solution that supports growers throughout the crop cycle,” says CEO Marc Salvany.

After the management buyout on October 1, 2025, Gavita International is led by Marc Salvany (CEO) and Ad van der Vorst (CFO). With the launch of the Agrolux Actuator System, Gavita International is presenting not only a future-ready platform, but also its new strategic location: this presentation is the basis for the future developments of the globally operating lighting systems supplier.

The launch of the Agrolux brand underlines the company’s strategic move towards a fully integrated solution for professional growers.

© Agrolux

Agrolux Operating System
“The Agrolux Operating System is a future-proof and user-friendly platform that enables professional farmers to improve performance, efficiency and return on investment, while actively contributing to a more sustainable, circular and resilient horticultural ecosystem,” explained Marc. “It supports electrical power and wireless communication, the Horticultural Lighting Protocol (HLP), and can work seamlessly with a climate computer or standalone. The system is also fully compatible with all generations of Agrolux (LED) luminaires as well as third-party brands.”

The Agrolux Operating System has capabilities on its development page, such as AI-based lighting strategies and integration with sensors, providing advanced automation, monitoring and control for modern greenhouse operations. The Agrolux Operating System protects existing investments while enabling smarter and more sustainable farming.

LYRA: the modular product platform of the future, fully complementary to the Agrolux portfolio
Together with the Agrolux Operating System, Gavita International is proudly developing LYRA; A new modular and future product platform to support current and next generation greenhouses. “At the heart of the LYRA platform is a modular design that supports multiple applications, including multi-channel configurations to enable lighting strategies, combined with a flexible power range from 340W to 1200W, depending on the producer’s requirements.”

The LYRA is designed around a single driver housing concept that allows LED modules to be added, upgraded and adjusted, ensuring the luminaire adapts to evolving technology, regulations and grower needs. Together with LYRA, the Agrolux OS system will continue to offer renewed features and innovations to the product platform.

LYRA complements the entire Agrolux (LED) luminaire portfolio, and the Agrolux Operating System supports all generations of Agrolux (LED) luminaires. “Together, they are designed to offer the professional greenhouse grower as much as possible
flexibility and long-term certainty in a rapidly evolving technology innovation landscape.”

LYRA will initially be available in a 4-channel version.

The defining moment
“Unveiling the Agrolux Operating System and previewing LYRA at Fruit Logistic is a defining moment for our company. This presentation marks a significant and exciting chapter for Gavita International, thanks to our dedicated team and the continued support of our trusted partners and respected growers. We look forward to meeting visitors in Berlin and showcasing our new developments,” said Marc.

Live demonstration at Fruit Logistica
At Fruit Logistica 2026, Gavita International will demonstrate the Agrolux operation
System live at stand A-46 in the Dutch Pavilion (Hall 3.2), seen first hand.
LIRA

Appointments for a demonstration can be booked online.

For more information:
Gavita International
(email protected)
www.agrolux.com

Related Topics:
Continue Reading

Cannabis News

Critical updates for cannabis taxpayers as the 2025 filing deadline approaches

Published

22 hours ago

on

April 5, 2026

By











With the April 2025 tax return filing deadline fast approaching, cannabis companies must once again face the burden of Section 280E of the Internal Revenue Code (“Section 280E”). Despite significant developments over the past year — including a major executive order from President Trump and the IRS, for the first time, disclosing legal reasoning funds to keep state cannabis “within the meaning” of Section 280E — taxpayer scrutiny remains the same.

However, whether substantively or psychologically, these recent developments weigh on how taxpayers should deal with Section 280E. Below, we summarize the key developments that cannabis taxpayers should be aware of as they prepare their 2025 returns.

As discussed in previous publications, Section 280E provides: “(e) no deduction or credit shall be allowed for any amount paid or incurred in the course of any trade or business during the taxable year, if such trade or business (or the activities constituting such trade or business) is trafficking in controlled substances (controlled substance classes I and II prohibited by State or Federal law).

Because cannabis is now listed as a Schedule I controlled substance under the Controlled Substances Act (CSA), the IRS has consistently maintained that Section 280E applies to state-licensed cannabis businesses, significantly increasing their effective tax rates.

Read more at JD above










Continue Reading

Cannabis News

Louisiana Senators Approve Bill To Allow Medical Marijuana Use In Hospitals For Terminally Ill Patients

Published

22 hours ago

on

April 5, 2026

By

A Louisiana Senate panel has advanced a bill to allow patients with terminal and irreversible conditions to use medical marijuana in hospitals.

The Senate Health and Welfare Committee approved the legislation, SB 270 (D) by Sen. Katrina Jackson-Andrews, with amendments, on a voice vote Wednesday.

“This bill was introduced at the request of voters who believe that therapeutic medical marijuana, which is already legal in this state, should be offered in hospitals when the terminally ill or otherwise need the comfort of this medicine,” Jackson-Andrews said before the vote.

Under the proposal, hospitals would have to create written policies to allow covered patients to consume medical cannabis in forms other than smoking or vaporizing it.

Under an amendment approved by the panel, emergency or outpatient departments would be exempt from the policy. The revised legislation also clarifies that patients and primary caregivers are responsible for obtaining and administering medical marijuana, which “must be securely stored at all times in a sealed container provided by the patient.”

Health care professionals and staff would be prohibited from “administering, storing, retrieving, or assisting a patient with medical marijuana.” the text he says

The amendment, which the proponent worked out with the help of the Louisiana Hospital Association, also allows hospitals to opt out of the policy if federal officials take action against any health care facility in the state regarding the use of medical cannabis, instead of allowing those specifically targeted to stop serving.

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Meanwhile, in Louisiana, the Senate Health and Welfare Committee passed a bill last week create a pilot psychedelic-assisted therapy program using opioid settlement dollars to fund clinical trials to develop alternative treatments such as psilocybin and ibogaine.

Lawmakers are also considering a bill creating a pilot program to legalize marijuana for adults in the state, in the end, to determine whether the reform should be expanded and permanently codified.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Cresco Labs gets Texas license

Published

2 days ago

on

April 4, 2026

By











Cresco Labs has obtained a Texas Compassionate Use Program License. It is a vertically integrated license that allows Cresco Labs to cultivate, process and distribute medical cannabis.

“Texas patients deserve access to consistent, quality medicine, and we’re excited. Our track record in medical markets reflects our ability to build strong programs that put patients and communities first,” said Charlie Bachtell, CEO of Cresco Labs. “Winning a license in Texas through a merit-based application demonstrates Cresco Labs’ deep regulatory expertise and thoughtful approach to meaningful local engagement. Organic licenses enable capital-efficient market entry, and our cash flow and balance sheet give us the financial flexibility to invest in and grow our scaled platform for the long term.”

This license advances Cresco Labs’ state-by-state growth strategy and ensures access to one of the largest patient populations in the United States. Texas is the nation’s second most populous state, approaching 30 million people, and continues to see ongoing legislative efforts to improve patient access and expand eligibility.










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media